logo
Select company
Select metric
$ -54.14MEarning Before Interest & Taxes (EBIT)
VS
Market
15
Sector
34
Industry
46
History
98
$ 4.41Close
$ 2.88 - $ 4.9 52-Week Range
Ticker Information

Ticker

ABUS

Company Name

ARBUTUS BIOPHARMA CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ARBUTUS BIOPHARMA CORP - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ABUS - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -54.14M
3/31/2025$ -76.45M
12/31/2024$ -69.78M
9/30/2024$ -76.55M
6/30/2024$ -76.92M
3/31/2024$ -74.08M
12/31/2023$ -72.39M
9/30/2023$ -74.75M
6/30/2023$ -71.83M
3/31/2023$ -68.61M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ARBUTUS BIOPHARMA CORP's latest trailing twelve months (TTM) EBIT stands at $ -67.15M.
  • Over the past 5 years, ARBUTUS BIOPHARMA CORP's average EBIT has been $ -68.67M.
  • The median EBIT for ARBUTUS BIOPHARMA CORP during this period was $ -68.74M
  • ARBUTUS BIOPHARMA CORP reached its highest EBIT over the past 5 years at $ -54.14M.
  • The lowest EBIT recorded by ARBUTUS BIOPHARMA CORP in the same timeframe $ -76.92M

ARBUTUS BIOPHARMA CORP's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
ZBIO : ZENAS BIOPHARMA INC $ -176.76MQURE : UNIQURE NV $ -135.06MNUVB : NUVATION BIO INC $ -202.21MVIR : VIR BIOTECHNOLOGY INC $ -549.95MBCYC : BICYCLE THERAPEUTICS PLC $ -248.02MIMNM : IMMUNOME INC $ -212.39MRLAY : RELAY THERAPEUTICS INC $ -311.55MCAPR : CAPRICOR THERAPEUTICS INC $ -69.98MALMS : ALUMIS INC $ -236.08MTSHA : TAYSHA GENE THERAPIES INC $ -92.64M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

ABUS - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -76.92M

Minimum

Jun 30, 2024

$ -54.14M

Maximum

Jun 30, 2025

$ -68.67M

Average

$ -68.74M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.62M with a standard deviation of $ 130.62M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442.4M
average$ 28.62M
median$ 897.02K
std$ 130.62M